Distribution characteristics and genomic epidemiology of carbapenem-resistant Acinetobacter baumannii
DOI:
https://doi.org/10.3855/jidc.20580Keywords:
Acinetobacter baumannii, carbapenem, distribution, genomic epidemiology, resistanceAbstract
Introduction: Carbapenem-resistant Acinetobacter baumannii poses significant challenges in clinical settings due to rapid emergence and limited treatment options. This study aimed to investigate the distribution characteristics and genomic epidemiology of carbapenem-resistant A. baumannii in a regional healthcare context to identify novel trends and genetic determinants.
Methodology: A total of 120 clinically isolated strains of carbapenem-resistant A. baumannii were collected in our hospital from July 2021 to June 2023. Distribution characteristics were assessed based on infection sites. Whole genome sequencing was performed to profile resistance genes.
Results: The resistance rates of carbapenem-resistant A. baumannii to 15 antibiotics, such as tobramycin and amikacin, increased yearly during the three years (p < 0.05). Respiratory tract and urinary tract infections were dominant. Whole genome sequencing revealed high prevalence rates of β-lactamase genes (AmpC: 82.5%, OXA-23: 70.83%, IMP-1: 54.17%) and efflux system genes (adeB: 78.33%, adeJ: 93.33%, adeG: 90.00%).
Conclusions: Our study provides novel insights by identifying significant increases in antibiotic resistance and revealing critical genomic co-occurrence patterns of resistance genes in carbapenem-resistant A. baumannii. These findings enhance the understanding of resistance mechanisms and support targeted strategies for improved prevention, control, and monitoring of nosocomial infections.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2026 Ruixiang Luo, Jinpei Lu, Yu Nong, Hong Zhang, Minmin Tian, Yufeng Wang, Shan Huang, Nannan Dai, Yihua Wang

This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).

